Evonik Industries (EVK) CMD 2025 summary

Strategic vision and organizational transformation

• Introduced a new group structure with two segments: Custom Solutions (innovation-driven, niche markets) and Advanced Technologies (efficiency-driven, operational excellence), enabling differentiated management and capital allocation.

• New vision positions the company as "Industry's Superforce," focusing on a leading portfolio, sustainable innovation, regional balance (one-third sales in Americas, Asia, Europe), and team excellence.

• Major portfolio steps by 2027 include divesting the C4 business, executing strategic options for German infrastructure sites, and ongoing optimization in Health Care and Coatings & Adhesive Resins.

• Emphasis on a balanced global footprint, with targeted investments in Asia, increased local-for-local production, and regional management responsibilities.

• Cultural transformation prioritizes respect, collaboration, accountability, and performance, with explicit rejection of right-wing populism.

Financial targets and capital allocation

• Targeting €1 billion additional EBITDA by 2027 (base year 2023), split equally between growth and optimization, with €400 million already achieved in 2024.

• ROCE target set at 11% by 2027, with >40% cash conversion rate and integration into executive compensation.

• Free cash flow generation expected to reach €5.5 billion over the next three years, with sustainable CapEx of €850–900 million per year, split 50/50 between growth and maintenance.

• Capital allocation priorities: 50% to CapEx, 30% to dividends, 20% to deleveraging; no significant M&A until 2027, with share buybacks and targeted M&A possible post-2027.

• Plans >50% of sales from Next Generation Solutions by 2030 and a 25% reduction in GHG emissions (scope 1 & 2, vs. 2021).

Growth and optimization initiatives

• €500 million EBITDA growth from investments in PA12, Silica, Alkoxides, Metal Oxides, biosurfactants, and membranes.

• €500 million net savings from the "Evonik Tailor Made" reorganization, business optimization, and procurement improvements.

• "Evonik Tailor Made" aims to reduce up to 2,000 employees by 2026, cut hierarchy levels, and achieve significant cost reductions.

• Innovation Growth Areas expected to generate €1.5 billion additional sales by 2032 at >20% margin, focusing on biosolutions, circular economy, and energy transition.

• Process innovation (Next Generation Technologies) to drive cost leadership and GHG reduction, with projects like waste heat upcycling and process redesign.